Prof. Ponikowski discusses his results on the use of Guided Diuretic Therapy using Reprieve/RenalGuard technology in acute decompensated heart failure patients, which he presented as a late breaking clinical trial at the European Society of Cardiology's Heart Failure Congress in Vienna, May 2019.The Reprieve Technology is available for investigational use only in the United States.Cast: RenalGuard Solutions